Agile Therapeutics, Inc.

AGRX · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$2,557$5,246$19,143$14,463
Short-Term Investments$0$0$0$40,008
Receivables$3,392$3,377$1,533$865
Inventory$2,738$1,332$966$0
Other Curr. Assets$843$1,403$2,283$1,449
Total Curr. Assets$9,530$11,358$23,925$56,785
Property Plant & Equip (Net)$487$872$13,396$14,381
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$238$2,012$2,012$1,896
Total NC Assets$725$2,884$15,408$16,277
Other Assets$0$0$0$0
Total Assets$10,255$14,242$39,333$73,062
Liabilities
Payables$9,574$7,734$8,707$3,867
Short-Term Debt$2,072$1,745$17,183$138
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$9,131$3,908$3,388$3,348
Total Curr. Liab.$20,777$13,387$29,278$7,353
LT Debt$100$466$784$16,381
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$5,696$5,934$0$0
Total NC Liab.$5,796$6,400$784$16,381
Other Liabilities$0$0$0$0
Cap. Leases$466$785$959$138
Total Liabilities$26,573$19,787$30,062$23,734
Equity
Pref Stock$0$0$0$0
Common Stock$4$4$12$9
Retained Earnings-$423,168-$408,702-$387,117-$312,223
AOCI$0$0$0$3
Other Equity$406,846$403,153$396,376$361,539
Total Equity-$16,318-$5,545$9,271$49,328
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$10,255$14,242$39,333$73,062
Net Debt-$385-$3,035-$1,176$2,056
Agile Therapeutics, Inc. (AGRX) Financial Statements & Key Stats | AlphaPilot